Results for
"[search-keyword]"
Sponsor content
165 result(s) found, displaying 51 to 60
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYBELSUS semaglutide 14 mg tablet blister pack.
-
Australian Public Assessment Report (AusPAR)Rybelsus (semaglutide) has been approved for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.
-
Australian Public Assessment Report (AusPAR)AusPAR for SOGROYA (somapacitan) indicated for replacement of endogenous growth hormone in adults with growth hormone deficiency.
-
Designation or determinationOrphan drug
-
Designation or determinationPriority review
-
Cancellation by sponsorRequested by Novo Nordisk Pharmaceuticals Pty Ltd
-
Cancellation by sponsorRequested by Novo Nordisk Pharmaceuticals Pty Ltd
-
Cancellation by sponsorRequested by Novo Nordisk Pharmaceuticals Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XULTOPHY insulin degludec 100 units/mL liraglutide 3.6 mg/mL solution for injection pre-filled pen 3 mL.
-
Prescription medicine registrationActive ingredients: Semaglutide.